Xiaoqi Li Selected Research

MicroRNAs (MicroRNA)

1/2022	Gga-miR-30c-5p Suppresses Avian Reovirus (ARV) Replication by Inhibition of ARV-Induced Autophagy via Targeting ATG5.
1/2022	Gga-miR-29a-3p suppresses avian reovirus-induced apoptosis and viral replication via targeting Caspase-3.
1/2021	Integrated bioinformatics analysis revealed the regulation of angiogenesis by tumor cells in hepatocellular carcinoma.
1/2020	Epigenetic Upregulation of Chicken MicroRNA-16-5p Expression in DF-1 Cells following Infection with Infectious Bursal Disease Virus (IBDV) Enhances IBDV-Induced Apoptosis and Viral Replication.
1/2020	gga-miR-27b-3p enhances type I interferon expression and suppresses infectious bursal disease virus replication via targeting cellular suppressors of cytokine signaling 3 and 6 (SOCS3 and 6).
1/2018	gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK.
1/2018	MicroRNA gga-miR-130b Suppresses Infectious Bursal Disease Virus Replication via Targeting of the Viral Genome and Cellular Suppressors of Cytokine Signaling 5.
1/2018	gga-miR-454 suppresses infectious bursal disease virus (IBDV) replication via directly targeting IBDV genomic segment B and cellular Suppressors of Cytokine Signaling 6 (SOCS6).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoqi Li Research Topics

Disease

32	Neoplasms (Cancer) 02/2024 - 06/2009
21	Infections 01/2023 - 02/2012
9	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2023 - 09/2015
9	Virus Diseases (Viral Diseases) 01/2023 - 01/2013
8	Axial Spondyloarthritis 09/2022 - 01/2019
7	Inflammation (Inflammations) 08/2023 - 01/2017
5	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2019
5	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2017
4	Melanoma (Melanoma, Malignant) 05/2023 - 11/2019
3	Lymphoma (Lymphomas) 01/2024 - 01/2020
3	Wounds and Injuries (Trauma) 10/2023 - 11/2022
3	Carcinogenesis 01/2023 - 01/2021
3	Sacroiliitis 09/2022 - 01/2019
3	Ankylosing Spondylitis 01/2022 - 01/2020
3	Hemorrhage 08/2017 - 10/2013
3	Pathologic Constriction (Stenosis) 08/2017 - 09/2015
3	Vesicular Stomatitis 01/2017 - 09/2013
3	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2011 - 09/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2024 - 01/2010
2	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 01/2021
2	Hypoxia (Hypoxemia) 02/2024 - 01/2021
2	Macular Degeneration (Age-Related Maculopathy) 02/2024 - 03/2023
2	Disease Progression 12/2023 - 07/2016
2	Cataract (Cataracts) 11/2023 - 01/2020
2	Breast Neoplasms (Breast Cancer) 08/2023 - 09/2015
2	Bites and Stings (Sting) 01/2023 - 05/2022
2	Atrial Fibrillation 11/2022 - 08/2017
2	Pain (Aches) 11/2022 - 01/2022
2	Fever (Fevers) 11/2022 - 07/2020
2	Adenocarcinoma 11/2022 - 01/2022
2	Non-Radiographic Axial Spondyloarthritis 09/2022 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 12/2017 - 07/2016
2	Toxoplasmosis 09/2016 - 07/2016
2	Acute Coronary Syndrome 02/2015 - 07/2013
1	Ascites 04/2024
1	Multiple Myeloma 03/2024
1	Reperfusion Injury 03/2024
1	Choroidal Neovascularization 02/2024
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024
1	Endometrial Neoplasms (Endometrial Cancer) 01/2024
1	Carcinoma (Carcinomatosis) 12/2023

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2012
10	Interferon Type IIBA 01/2023 - 01/2013
9	ixekizumabIBA 09/2022 - 01/2019
8	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2018
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2018
5	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2022
4	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020
4	Clopidogrel (Plavix)FDA Link 03/2015 - 07/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 08/2023
3	IonsIBA 08/2023 - 07/2016
3	IronIBA 08/2023 - 12/2016
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2010
3	SolutionsIBA 11/2018 - 07/2016
3	Cytochrome P-450 CYP2C19IBA 03/2015 - 10/2013
2	Indicators and Reagents (Reagents)IBA 02/2024 - 01/2022
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 11/2023 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2022
2	icaritinIBA 12/2022 - 05/2022
2	CytokinesIBA 11/2022 - 11/2022
2	C-Reactive ProteinIBA 09/2022 - 01/2020
2	Interleukin-17 (Interleukin 17)IBA 09/2022 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	Adalimumab (Humira)FDA Link 01/2021 - 01/2020
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2019
2	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2020
2	GoldIBA 11/2018 - 12/2016
2	gluconic acid (gluconate)FDA LinkGeneric 12/2017 - 07/2016
2	ZincIBA 12/2017 - 07/2016
2	Zinc Oxide FDA Link 12/2017 - 07/2016
2	Warfarin (Coumadin)FDA LinkGeneric 08/2017 - 04/2015
2	usnic acidIBA 09/2016 - 07/2016
1	theasinensin AIBA 04/2024
1	Metal-Organic FrameworksIBA 04/2024
1	MethyltransferasesIBA 03/2024
1	Beclin-1IBA 03/2024
1	Small Interfering RNA (siRNA)IBA 02/2024
1	CarcinogensIBA 02/2024
1	Retinaldehyde (Retinal)IBA 02/2024
1	Heme Oxygenase-1IBA 02/2024
1	Thymidine Monophosphate (TMP)IBA 02/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024
1	Drug CarriersIBA 01/2024
1	Fluorouracil (Carac)FDA LinkGeneric 01/2024
1	Histone MethyltransferasesIBA 01/2024
1	apatinibIBA 12/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2023
1	camrelizumabIBA 12/2023
1	Capsules (Microcapsules)IBA 11/2023

Therapy/Procedure

16	Therapeutics 01/2024 - 12/2016
8	Trachelectomy 01/2023 - 09/2015
4	Drug Therapy (Chemotherapy) 01/2024 - 01/2017
4	Lymph Node Excision (Lymph Node Dissection) 12/2023 - 01/2019
3	Immunotherapy 01/2023 - 09/2022
3	Hysterectomy 01/2022 - 01/2016
2	Neoadjuvant Therapy 01/2023 - 01/2019
2	Radiotherapy 11/2022 - 01/2019
2	Intrauterine Devices (Intrauterine Device) 08/2017 - 06/2016
1	Intravitreal Injections 02/2024
1	Gastrectomy 12/2023